immune system
• thymocyte development largely blocked at DN3 stage
(J:106246)
• at 4-6 weeks of age, 60% of double negative thymocytes are apoptotic
(J:106246)
• Tcr Dbeta1-Jbeta1 rearrangements not detected
(J:107306)
• Tcr Dbeta2-Jbeta2 found but at 25 fold less than normal levels
(J:107306)
• severely reduced Rag mediated cleavages at Dbeta or Jbeta
(J:107306)
|
• at 4-6 weeks of age, 80% of double positive thymocytes are apoptotic
(J:106246)
• Tcr Dbeta1-Jbeta1 rearrangements not detected
(J:107306)
• Tcr Dbeta2-Jbeta2 found but at 25 fold less than normal levels
(J:107306)
• Tcr Dbeta1-Jbeta2 rearrangements seen but at 1% of normal levels
(J:107306)
• Tcr Dbeta1-Jbeta2 usually retained at least partial Dbeta2 sequence, only 21% were normal
(J:107306)
|
neoplasm
hematopoietic system
• thymocyte development largely blocked at DN3 stage
(J:106246)
• at 4-6 weeks of age, 60% of double negative thymocytes are apoptotic
(J:106246)
• Tcr Dbeta1-Jbeta1 rearrangements not detected
(J:107306)
• Tcr Dbeta2-Jbeta2 found but at 25 fold less than normal levels
(J:107306)
• severely reduced Rag mediated cleavages at Dbeta or Jbeta
(J:107306)
|
• at 4-6 weeks of age, 80% of double positive thymocytes are apoptotic
(J:106246)
• Tcr Dbeta1-Jbeta1 rearrangements not detected
(J:107306)
• Tcr Dbeta2-Jbeta2 found but at 25 fold less than normal levels
(J:107306)
• Tcr Dbeta1-Jbeta2 rearrangements seen but at 1% of normal levels
(J:107306)
• Tcr Dbeta1-Jbeta2 usually retained at least partial Dbeta2 sequence, only 21% were normal
(J:107306)
|